High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals

Dimitrios Farmakis1, Dimitrios Richter2, Genovefa Chronopoulou3

  • 1Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Insights

High-sensitivity cardiac troponin (hs-cTn) assays detect low troponin levels in healthy individuals. This biomarker aids in predicting cardiovascular events and mortality, enhancing risk assessment in primary prevention.

Area of Science:

  • Cardiology
  • Biomarkers
  • Preventive Medicine

Background:

  • Cardiac troponins (Troponin I and T) are vital for diagnosing acute coronary syndromes.
  • They also serve as independent predictors for various clinical conditions.
  • High-sensitivity assays (hs-cTn) detect minute troponin concentrations in asymptomatic individuals.

Purpose of the Study:

  • To summarize evidence on hs-cTnI's role in predicting cardiovascular events and mortality in healthy individuals.
  • To evaluate the additive value of hs-cTnI to existing risk stratification methods.
  • To provide guidance for integrating hs-cTnI into cardiovascular prevention strategies.

Main Methods:

  • Systematic review and evidence synthesis by a panel of Greek experts.
  • Focus on studies involving apparently healthy and asymptomatic individuals.
  • Analysis of hs-cTnI's predictive capabilities and its incremental value over standard risk factors.

Main Results:

  • hs-cTnI is a strong predictor of cardiovascular events and mortality in the general population.
  • It offers additive value beyond established risk stratification tools.
  • Low concentrations of hs-cTnI in apparently healthy individuals indicate increased risk.

Conclusions:

  • hs-cTnI is a promising tool for cardiovascular risk stratification in apparently healthy individuals.
  • Its incorporation into preventive strategies can improve cardiovascular risk assessment.
  • Further research and clinical guidelines are needed for widespread adoption.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
185
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
29
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
31